Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brain Network Dysfunction as a Model for Schizophrenia: Connectivity Alterations using Ketamine and pharmacological MRI
2010-022772-31Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in schizophrenia comparing Esketamine with Placebo (2 arms). Primary endpoints: Resting-state functional connectivity (primary) and BOLD signal (primary). Started Feb 2011; status: completed.
02
Drugs
esketamine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2010-022772-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022772-31.